Literature DB >> 19448912

Technological profile assessment of voluntary HIV counseling and testing centers in Brazil.

Alexandre Grangeiro1, Maria Mercedes Escuder, Karina Wolffenbüttel, Ligia Rivero Pupo, Maria Ines Battistella Nemes, Paulo Henrique Nico Monteiro.   

Abstract

OBJECTIVE: To characterize and analyze technological profiles of voluntary HIV counseling and testing centers in Brazil.
METHODS: A structured self-completion questionnaire with 78 questions was used. This questionnaire was answered by 320 (83.6%) of the 383 Brazilian centers, in 2006. Responses that characterized the services' technological profile were analyzed using K-means clustering technique. Associations between the profiles described and the municipal contexts were analyzed using the chi-square and residue analysis for proportions, and ANOVA and Bonferroni for means.
RESULTS: Centers showed significant deficiencies to guarantee adequate services. A total of four technological profiles were identified. The 'care' profile (21.6%) predominated among the services instituted before 1993, in areas with high AIDS incidence and in large cities. The 'prevention' profile (30.0%), prevalent between 1994 and 1998, was the type that best complies with the Ministry of Health's norms, with better readiness and productivity indicators. The 'care and prevention' profile (26.9%), included in the AIDS services, predominated between 1999 and 2002, and developed the most comprehensive set of activities, including STD treatment. The 'testing' profile (21.6%) was the most precarious, found where the epidemic is most recent and with a lower number of people tested.
CONCLUSIONS: Counseling and testing centers constitute a set of heterogeneous services. In addition, service implementation guidelines have not been completely incorporated in Brazil, thus having and influence on low resolution and productivity indicators and also the inadequate development of prevention activities.

Entities:  

Mesh:

Year:  2009        PMID: 19448912     DOI: 10.1590/s0034-89102009000300006

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  5 in total

1.  Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial, São Paulo, Brazil.

Authors:  Thelma T Goncalez; Paula F Blatyta; Fernanda M Santos; Sandra Montebello; Sandra P D Esposti; Fatima N Hangai; Nanci A Salles; Alfredo Mendrone; Hong-Ha M Truong; Ester C Sabino; Willi McFarland
Journal:  Transfusion       Date:  2015-02-03       Impact factor: 3.157

2.  Factors Associated with Low Levels of HIV Testing among Men Who Have Sex with Men (MSM) in Brazil.

Authors:  Ana Maria Brito; Carl Kendall; Ligia Kerr; Rosa Maria Salani Mota; Mark Drew Crosland Guimarães; Inês Dourado; Adriana A Pinho; Adele Schwartz Benzaken; Sandra Brignol; Arthur L Reingold
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

3.  Test seeking: are healthcare professionals referring people to blood centers for infections marker testing?

Authors:  Elizabeth C Moreno; Roberta Bruhn; Ester C Sabino; Eduarda Bolina-Santos; Carolina Miranda; Anna Barbara Carneiro-Proietti; Maria Esther Lopes; Cesar de Almeida-Neto; Paula Loureiro; Ligia Capuani; Pedro L Takecian; Brian Custer; Thelma T Gonçalez
Journal:  Hematol Transfus Cell Ther       Date:  2019-02-18

4.  The Men Who Have Sex with Men HIV Care Cascade in Rio de Janeiro, Brazil.

Authors:  Rodolfo Castro; Marcelo Ribeiro-Alves; Renato Girade Corrêa; Monica Derrico; Katia Lemos; Jose Roberto Grangeiro; Beto de Jesus; Denise Pires; Valdilea G Veloso; Beatriz Grinsztejn
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

5.  State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013).

Authors:  Silvano Barbosa de Oliveira; Meritxell Sabidó; Ana Roberta Pati Pascom; Juliana Machado Gisiviez; Adele Schwartz Benzaken; Fábio Mesquita
Journal:  Hepatol Med Policy       Date:  2016-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.